Clinical study of RESPIRATORY SYNCYTIAL VIRUS (RSV) in adults who are immunocompromised and at high-risk for RSV.8.
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Respiratory syncytial virus vaccine Pfizer (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions
Most Recent Events
- 05 Jun 2023 New trial record